The forum is an annual event to convene the regenerative medicine community to focus on fulfilling the promise of the field, including best practices and business models. Keynote speakers and panelists will discuss scientific and clinical advances, trial design, venture funding and obtaining regulatory approval.
“As a leading international showcase of scientific discovery and commercialization in regenerative medicine, it’s imperative that we expose a younger generation of researchers and entrepreneurs to new ideas and best practices in the field,” said Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine, and a forum speaker.
With almost 70 speakers, the forum will include three keynote addresses, 10 panels that will cover all aspects of translation, from scientific updates to business models, as well as podium presentations on scientific discovery. In addition, 18 startup biotech companies will present their technologies to a group of venture capitalists and companies.
The forum is open to executives from biotechnology, pharmaceutical, medical device, and regenerative medicine companies; patient advocacy groups and medical research foundations; institutional investors from private equity and venture capital firms; academic researchers, clinical researchers and physicians; and those interested in health care innovation and personalized medicine.
The Young Minds Program is open to graduate students, post-doctoral students, or professional students enrolled in medicine, business or law programs. Students have access to all conference sessions and breaks for a reduced registration fee of $125. This does not include conference receptions, luncheons or dinners.
A limited number of Young Minds registrations are being offered, with more information at www.rmconferences.org
Launched in 2005, the Foundation hosted one of the first regulatory meetings with the U.S. Food and Drug Administration (FDA) on the topic of regenerative medicine, and was instrumental in the formation of STRAC, the Soldier Treatment and Regeneration Consortium, a precursor to the Armed Forces Institute of Regenerative Medicine (AFIRM), and the Washington, DC-based Alliance for Regenerative Medicine.
Through educational programs, translational conferences and public policy initiatives, the Foundation advocates for increased medical research, promotes the training and education of scientists, and facilitates the translation of therapies to patients.
Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany
02.05.2018 | FENS - Federation of European Neuroscience Societies
Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"
13.04.2018 | Max-Planck-Institut für molekulare Genetik
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology